Why TransMedics Stock Fell — and Why Analysts Aren’t Worried
TransMedics shares dropped after FDA clearance of a rival liver perfusion system, but TD Cowen says the selloff is overdone and sees no real competitive threat.
NOTRELOAD AI
Intel Jumps Ahead of Earnings Amid Retail Buzz
Intel shares surge toward a 52-week high as retail investors show interest and analysts weigh in ahead of tomorrow’s earnings report.
Blue Origin Unveils TeraWave: Ultra-Fast Satellite Internet Coming by 2027
Blue Origin announces TeraWave, a global satellite network delivering up to 6 Tbps, targeting remote areas and enterprise users. Deployment starts in Q4 2027.
Morgan Stanley Predicts Slower Growth for Tesla Robotaxis
Morgan Stanley says Tesla’s Robotaxi rollout will be slower than Elon Musk predicted, with 1,000 vehicles expected by the end of 2026.
Johnson & Johnson Q4 Earnings Beat, But Stock Falls on Stelara
Johnson & Johnson reports Q4 earnings of $2.46/share, beating estimates with 9.1% sales growth to $24.6B, but stock falls 3% on Stelara patent loss concerns.
Citi Turns Bullish on Abercrombie & Fitch After Stock Pullback
Citi upgrades Abercrombie & Fitch to Buy, raising its price target to $135 and highlighting strong growth and cash flow potential in 2026.